Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 1398

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 10
Chunk 1398
---
10)(iv) of Regulation S-K. 

Item 16. FORM 10-K SUMMARY

None.

74

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			EDESA BIOTECH, INC.

			Date: December 12, 2025

			/s/ Pardeep Nijhawan

			Pardeep Nijhawan, MD

			Director, Chief Executive Officer and Corporate Secretary (Principal Executive Officer)

			Date: December 12, 2025

			/s/ Peter Weiler

			Peter Weiler

			Chief Financial Officer

			(Principal Financial Officer)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Pardeep Nijhawan and Peter Weiler, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her, and in his or her name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and any of them or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated

			Signature

			Title

			Date

			/s/ Pardeep Nijhawan

			Director, Chief Executive Officer, and

			December 12, 2025

			Pardeep Nijhawan

			Corporate Secretary (Principal Executive Officer)

			/s/ Peter Weiler

			Chief Financial Officer

			December